Document is current
Any future updates will be listed below
-
Authors
Novis, Elan
Rautalin, Mervi
Amaria, Rodabe N.
Ascierto, Paolo A.
Blank, Christian U.
Faries, Mark B.
Grunhagen, Dirk J.
Gyorki, David E.
Hayes, Andrew J.
Kuijpers, Anke M. J.
Long, Georgina V.
Mammen, Joshua M. V.
Menzies, Alexander M.
Ross, Merrick I.
Rutkowski, Piotr
Tawbi, Hussein A.
Tetzlaff, Michael T.
Zager, Jonathan S.
Wargo, Jennifer A.
Hieken, Tina J.
van Akkooi, Alexander C. J. https://orcid.org/0000-0002-3262-6935
,
- License Information
-
More Information
Article History
First Online: 23 January 2026
Disclosure
: AvA has received honoraria from and/or served in consultancy or advisory roles for Amgen, Bristol-Myers Squibb, Daiichi Sankyo, Genmab, Menarini Silicon Biosystems, Merck Serono-Pfizer, MSD Merck, Neracare, Novartis, Pierre Fabre, Provectus, Replimune, Sanofi, Sirius Medical, SkylineDx, and 4SC. AvA has received research funding from Amgen, Merck Serono—Pfizer, and SkylineDx.
